Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRVg vs Imovax Rabies Pre-exposure Prophylaxis in Healthy Adults
NCT01784874Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2013
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Purified Vero cell rabies vaccine in rabies, sponsored by Sanofi. Started Feb 2013; status: completed.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT01784874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784874.